e-learning
resources
Virtual 2020
Pre-Congress Content
Management of chronic lung conditions
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Real-world treatment patterns of mepolizumab therapy in Canada
S. Noorduyn (Mississauga, Canada), L. Mbuagbaw (Hamilton, Canada), A. Gendron (Mississauga, Canada), M. Knutson (Mississauga, Canada), N. Sriskandarajah (Mississauga, Canada), J. Lee (Toronto, Canada)
Source:
Virtual Congress 2020 – Management of chronic lung conditions
Session:
Management of chronic lung conditions
Session type:
E-poster session
Number:
1680
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Noorduyn (Mississauga, Canada), L. Mbuagbaw (Hamilton, Canada), A. Gendron (Mississauga, Canada), M. Knutson (Mississauga, Canada), N. Sriskandarajah (Mississauga, Canada), J. Lee (Toronto, Canada). Real-world treatment patterns of mepolizumab therapy in Canada. 1680
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Real-world treatment patterns of benralizumab therapy for patients with severe asthma
Source: Virtual Congress 2020 – Diagnosis and management of asthma
Year: 2020
Real-world effectiveness and cost-effectiveness of asthma step-up options: A UK comparison of extrafine hydrofluoroalkane-beclometasone and combination therapy
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Does adherence to ICS/LABA therapy affect response to mepolizumab in the treatment of severe asthma?
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Severe asthma and biologic therapies during COVID-19: supporting patients care with home administration of mepolizumab and omalizumab
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
The response to combination therapy treatment regimens in severe/difficult-to-treat asthma
Source: Eur Respir J 2008; 32: 1237-1242
Year: 2008
Cost consequences of tiotropium plus existing therapy
versus
existing therapy alone following one year of treatment in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 5s
Year: 2001
Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma
Source: Eur Respir J, 55 (5) 1902259; 10.1183/13993003.02259-2019
Year: 2020
Oral glucocorticoid-sparing effects of mepolizumab. A real-life study.
Source: International Congress 2018 – Innovative therapies in asthma and COPD
Year: 2018
Characterising individual response to mepolizumab treatment
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020
Year: 2021
Safety profile of tiotropium add-on therapy in paediatric patients by gender
Source: International Congress 2018 – Innovative therapies in asthma and COPD
Year: 2018
Long-term treatment with fluticasone propionate/formoterol fumarate (FLUT/FORM) combination therapy is well-tolerated and provides sustained effectiveness in paediatric patients with asthma
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011
Cost-effectiveness of fixed-dose combinations therapies for COPD in Spain
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017
Evaluation of efficacy and safety of budesonide/formeterol combination therapy in asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 314s
Year: 2006
Efficacy of different dosing regimens of azithromycin in a real-world severe asthma cohort
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Response to mepolizumab treatment is sustained across 4-weekly dosing periods
Source: ERJ Open Res, 6 (3) 00068-2020; 10.1183/23120541.00068-2020
Year: 2020
Evaluating the efficacy of chronic therapy with tiotropium in COPD through discontinuation of treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 245s
Year: 2002
Characteristics of patients receiving mepolizumab in real-world practice –REALITI-A study
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018
Economic evaluation of the impact of exacerbation frequency in COPD patients treated with single-inhaler triple therapy in Spain: The IMPACT trial
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Real-world oral glucocorticoid-sparing effect of benralizumab in severe asthma
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept